Literature DB >> 22426060

CD90 is identified as a marker for cancer stem cells in high-grade gliomas using tissue microarrays.

Phillip V Parry, Johnathan A Engh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22426060     DOI： 10.1227/01.neu.0000413227.80467.92

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  11 in total

1.  Stemness-Related Markers in Cancer.

Authors:  Wenxiu Zhao; Yvonne Li; Xun Zhang
Journal:  Cancer Transl Med       Date:  2017-06-08

2.  Up-regulation of THY1 attenuates interstitial pulmonary fibrosis and promotes lung fibroblast apoptosis during acute interstitial pneumonia by blockade of the WNT signaling pathway.

Authors:  Lin Chen; Rong-Zhen Tang; Jia Ruan; Xiao-Bo Zhu; Yang Yang
Journal:  Cell Cycle       Date:  2019-03-04       Impact factor: 4.534

3.  Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic Factors.

Authors:  Fang Li; Xinjian Liu; John H Sampson; Darell D Bigner; Chuan-Yuan Li
Journal:  Cancer Res       Date:  2016-06-30       Impact factor: 12.701

Review 4.  Multiple roles of CD90 in cancer.

Authors:  Atul Kumar; Anshuman Bhanja; Jina Bhattacharyya; Bithiah Grace Jaganathan
Journal:  Tumour Biol       Date:  2016-06-23

5.  Selection and Evaluation of Specific Single Chain Antibodies against CD90, a Marker for Mesenchymal and Cancer Stem Cells.

Authors:  Bahareh Moazen; Amir Zarrinhaghighi; Foroogh Nejatollahi
Journal:  Rep Biochem Mol Biol       Date:  2018-10

6.  Glioblastoma specific antigens, GD2 and CD90, are not involved in cancer stemness.

Authors:  Seon Rang Woo; Young Taek Oh; Jae Yeol An; Bong Gu Kang; Do-Hyun Nam; Kyeung Min Joo
Journal:  Anat Cell Biol       Date:  2015-03-20

7.  Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.

Authors:  Amanda Tivnan; Tatjana Heilinger; Joanne M Ramsey; Gemma O'Connor; Jenny L Pokorny; Jann N Sarkaria; Brett W Stringer; Bryan W Day; Andrew W Boyd; Ella L Kim; Holger N Lode; Sally-Ann Cryan; Jochen H M Prehn
Journal:  Oncotarget       Date:  2017-03-07

8.  Thy1 (CD90) expression is regulated by DNA methylation during adipogenesis.

Authors:  E'Lissa M Flores; Collynn F Woeller; Megan L Falsetta; Martha Susiarjo; Richard P Phipps
Journal:  FASEB J       Date:  2018-10-30       Impact factor: 5.834

9.  Gene expression profiling of histiocytic sarcomas in a canine model: the predisposed flatcoated retriever dog.

Authors:  Kim M Boerkamp; Marieke van der Kooij; Frank G van Steenbeek; Monique E van Wolferen; Marian J A Groot Koerkamp; Dik van Leenen; Guy C M Grinwis; Louis C Penning; Erik A C Wiemer; Gerard R Rutteman
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

10.  Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progression.

Authors:  Ching-Yu Lin; Shun-Tai Yang; Shing-Chuan Shen; Yi-Chen Hsieh; Fei-Ting Hsu; Cheng-Yu Chen; Yung-Hsiao Chiang; Jian-Ying Chuang; Kai-Yun Chen; Tsung-I Hsu; Wan-Chong Leong; Yu-Kai Su; Wei-Lun Lo; Yi-Shian Yeh; Yudha Nur Patria; Hsiu-Ming Shih; Che-Chang Chang; Szu-Yi Chou
Journal:  Mol Oncol       Date:  2018-04-17       Impact factor: 6.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.